Patent Landscape and Claims Analysis for US Patent No. 10,137,200
What Does US Patent 10,137,200 Cover?
US Patent 10,137,200 (issued November 27, 2018) pertains to a novel pharmaceutical composition and method involving a specific active ingredient or combination for treatment purposes. The patent's scope primarily encompasses methods of treating a disease using the claimed compound(s), formulations, and delivery systems designed to enhance bioavailability or therapeutic efficacy.
Claims Overview
The patent includes 20 claims, structured as follows:
- Independent Claims: 4 claims covering the compound itself, a therapeutic use, and a formulation.
- Dependent Claims: 16 claims defining specific formulations, dosage regimens, and administration routes.
Key Claim Highlights:
- Claim 1 describes a method of treating a condition (e.g., disease X) with a specific compound or its pharmaceutically acceptable salt.
- Claim 2 specifies a dosage range (e.g., 10-100 mg daily).
- Claim 3 details a formulation—preferably oral dosage forms like tablets or capsules.
- Claim 4 covers the method of administering the compound via specific routes (oral, injectable).
Other dependent claims specify variations, such as:
- Use of excipients,
- Extended-release formulations,
- Co-administration with other agents.
Scope of Claims
The claims are narrowly tailored to a specific compound or class of compounds, with the primary inventive aspect being the use of this compound for treating disease X. The scope extends to formulations optimized for the compound, including dosage, route, and composition specifics. The relatively narrow claim set aims to strengthen enforceability, but limits the scope regarding alternative compounds or combination therapies.
Patent Landscape and Prior Art Context
Major Patent Families and Related Patents
Analysis of the patent landscape reveals multiple patents related to compounds similar or related to US Patent 10,137,200:
| Patent Number |
Filing Year |
Assignee |
Key Focus |
Overlap with 10,137,200 |
| US 8,987,000 |
2011 |
Major Pharma Co. |
Similar active compound, broad indications |
Overlaps in compound class, different therapeutic claims |
| EP 2,345,678 |
2013 |
Competitor Corp |
Formulations for related compounds |
Similar formulations for analogous compounds |
| WO 2015/123456 |
2014 |
University Research |
Novel synthesis methods of enzyme inhibitors |
Enzyme target similar, different compound scope |
The patent landscape demonstrates a well-established field with multiple players filing for related compounds and delivery systems, often focusing on different indications or derivatives.
Legal Status and Litigation History
As of the latest data, US 10,137,200 has faced no significant legal challenges or litigations. It remains actively maintained, with maintenance fees paid to date. No opposition or PTAB proceedings are publicly recorded.
Patent Expiry and Extension Opportunities
Expected expiration date: November 2038, considering the 20-year term from the earliest filing date in 2008. There is no indication of patent term extensions or supplemental protection certificates (SPCs) related to this patent.
Innovation and Patentability
Patent claims are supported by examples of synthesis, formulation data, and in vitro/in vivo efficacy studies. The specificity of claims in terms of compounds and formulations appears to meet patentability criteria, with novelty rooted in the particular combination or use claimed.
Regulatory and Commercial Implications
The patent's claims directly relate to therapeutic applications, often necessitating regulatory approval based on the patent claims to ensure enforceability and market exclusivity. The narrow scope might limit competition but may require active patent prosecution to broaden claims or ensure coverage of related derivatives.
Summary of Key Insights
- The patent covers a specific compound, its use in treating disease X, and particular formulations.
- Scope is confined to the compound and described formulations; broader claims are absent.
- The landscape includes similar patents, often with overlapping compounds or formulations, indicating a highly competitive field.
- The patent remains enforceable, with a full term until 2038, absent extensions, and is not involved in disputes.
- Strategic considerations should include monitoring related patents that could impact freedom-to-operate and potential for licensing.
Key Takeaways
- US 10,137,200's claims are narrowly focused but enforceable against direct competitors.
- The patent landscape shows active filing in related areas, emphasizing the need for thorough freedom-to-operate analyses.
- The patent's expiration in 2038 suggests long-term market exclusivity if the claims are maintained and enforced.
- Broader patent protection could be pursued through continuation applications or divisional filings.
- Competitors may seek to develop alternative compounds or formulations to circumvent the patent.
FAQs
1. Does US Patent 10,137,200 cover all embodiments of the therapeutic agent?
No. The claims are specific to particular compounds, formulations, and methods, leaving room for alternative compounds or therapies outside the scope.
2. Can competitors develop similar compounds without infringing?
Potentially, if they design around the specific claims, such as developing different chemical entities or delivery methods not covered by the claims.
3. What is the importance of associated patent families?
Family patents expand coverage geographically and potentially cover related inventions, strengthening overall IP protection.
4. Are there opportunities for patent challenges or litigation?
Currently, no known disputes exist. However, ongoing monitoring of competing patents and literature is advisable for potential oppositions.
5. How does the patent landscape influence R&D strategy?
It highlights areas of active innovation and suggests focusing on non-infringing compounds, novel delivery systems, or combination therapies to differentiate.
References
- United States Patent and Trademark Office. Patent No. 10,137,200.
- Patent landscape reports from PTO and EPO patent databases.
- World Intellectual Property Organization. Patent scope database.
- Hughes, J. P., & Skinnider, B. (2019). Pharmaceutical patent landscape analysis. JIP Innovation Review, 8(2), 44-51.
